183 related articles for article (PubMed ID: 20696177)
1. Could genetic analysis be useful in reducing cerebrovascular risk in hypertensive subjects with hyperhomocysteinemia and patent foramen ovale? A 2-year follow-up study.
Mazza A; Montemurro D; L'Erario R; Chinaglia M; Piergentili C; Aggio S; Zanon F; Pastore G; Zanier A; Grassetto G; Zamboni S; Rubello D
Microvasc Res; 2010 Dec; 80(3):545-8. PubMed ID: 20696177
[TBL] [Abstract][Full Text] [Related]
2. Higher incidence of C677T polymorphism of the MTHFR gene in North Indian patients with vascular disease.
Bhargava S; Ali A; Parakh R; Saxena R; Srivastava LM
Vascular; 2012 Apr; 20(2):88-95. PubMed ID: 22375042
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
4. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
6. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
Hermans MP; Gala JL; Buysschaert M
Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
[TBL] [Abstract][Full Text] [Related]
7. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
8. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinaemia, low folate concentrations and MTHFR C677T mutation in abdominal aortic aneurysm.
Cao H; Hu X; Zhang Q; Li J; Liu B; Wang J; Shao Y; Zhang Z; Liu C; Hu H; Zhang J; Xin S
Vasa; 2014 May; 43(3):181-8. PubMed ID: 24797049
[TBL] [Abstract][Full Text] [Related]
10. Nutrigenetic impact of daily folate intake on plasma homocysteine and folate levels in patients with different methylenetetrahydrofolate reductase genotypes.
Messika AH; Kaluski DN; Lev E; Iakobishvili Z; Shohat M; Hasdai D; Mager A
Eur J Cardiovasc Prev Rehabil; 2010 Dec; 17(6):701-5. PubMed ID: 20421795
[TBL] [Abstract][Full Text] [Related]
11. Serum folate, total homocysteine levels and methylenetetrahydrofolate reductase 677C>T polymorphism in young healthy female Japanese.
Taguchi T; Mori H; Hamada A; Yamori Y; Mori M
Asia Pac J Clin Nutr; 2012; 21(2):291-5. PubMed ID: 22507617
[TBL] [Abstract][Full Text] [Related]
12. Association of Vitamin B12 Deficiency with Homozygosity of the TT MTHFR C677T Genotype, Hyperhomocysteinemia, and Endothelial Cell Dysfunction.
Shiran A; Remer E; Asmer I; Karkabi B; Zittan E; Cassel A; Barak M; Rozenberg O; Karkabi K; Flugelman MY
Isr Med Assoc J; 2015 May; 17(5):288-92. PubMed ID: 26137654
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinaemia, low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric venous thrombosis.
He JA; Hu XH; Fan YY; Yang J; Zhang ZS; Liu CW; Yang DH; Zhang J; Xin SJ; Zhang Q; Duan ZQ
Eur J Vasc Endovasc Surg; 2010 Apr; 39(4):508-13. PubMed ID: 19846322
[TBL] [Abstract][Full Text] [Related]
14. Distribution of 5,10-methylenetetrahydrofolate reductase (C667T) polymorphism and its association with red blood cell 5-methyltetrahydrofolate in the healthy Iranians.
Golbahar J; Fathi Z; Tamadon M
Clin Nutr; 2005 Feb; 24(1):83-7. PubMed ID: 15681105
[TBL] [Abstract][Full Text] [Related]
15. G1793A polymorphisms in the methylene-tetrahydrofolate gene: effect of folic acid on homocysteine levels.
Melo SS; Persuhn DC; Meirelles MS; Jordao AA; Vannucchi H
Mol Nutr Food Res; 2006 Aug; 50(8):769-74. PubMed ID: 16865747
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients.
Fekih-Mrissa N; Mrad M; Klai S; Mansour M; Nsiri B; Gritli N; Mrissa R
J Stroke Cerebrovasc Dis; 2013 May; 22(4):465-9. PubMed ID: 23642756
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease.
Liu CS; Chiang HC; Chen HW
Nutrition; 2004; 20(11-12):974-8. PubMed ID: 15561486
[TBL] [Abstract][Full Text] [Related]
18. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
[TBL] [Abstract][Full Text] [Related]
19. Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial.
Mazza A; Cicero AF; Ramazzina E; Lenti S; Schiavon L; Casiglia E; Gussoni G
J Biol Regul Homeost Agents; 2016; 30(3):921-927. PubMed ID: 27655522
[TBL] [Abstract][Full Text] [Related]
20. The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea.
Cho SE; Hong KS; Shin GJ; Chung WS
Clin Chem Lab Med; 2006; 44(9):1070-5. PubMed ID: 16958597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
